Obesity Pathogenesis: An Endocrine Society Scientific Statement - PubMed
- ️Sun Jan 01 2017
Review
Obesity Pathogenesis: An Endocrine Society Scientific Statement
Michael W Schwartz et al. Endocr Rev. 2017.
Abstract
Obesity is among the most common and costly chronic disorders worldwide. Estimates suggest that in the United States obesity affects one-third of adults, accounts for up to one-third of total mortality, is concentrated among lower income groups, and increasingly affects children as well as adults. A lack of effective options for long-term weight reduction magnifies the enormity of this problem; individuals who successfully complete behavioral and dietary weight-loss programs eventually regain most of the lost weight. We included evidence from basic science, clinical, and epidemiological literature to assess current knowledge regarding mechanisms underlying excess body-fat accumulation, the biological defense of excess fat mass, and the tendency for lost weight to be regained. A major area of emphasis is the science of energy homeostasis, the biological process that maintains weight stability by actively matching energy intake to energy expenditure over time. Growing evidence suggests that obesity is a disorder of the energy homeostasis system, rather than simply arising from the passive accumulation of excess weight. We need to elucidate the mechanisms underlying this "upward setting" or "resetting" of the defended level of body-fat mass, whether inherited or acquired. The ongoing study of how genetic, developmental, and environmental forces affect the energy homeostasis system will help us better understand these mechanisms and are therefore a major focus of this statement. The scientific goal is to elucidate obesity pathogenesis so as to better inform treatment, public policy, advocacy, and awareness of obesity in ways that ultimately diminish its public health and economic consequences.
Copyright © 2017 Endocrine Society.
Similar articles
-
Novel and emerging devices and operations in the treatment of obesity in children and adolescents.
Kang HS, DeAntonio J, Oiticica C, Lanning D, Browne A. Kang HS, et al. Semin Pediatr Surg. 2020 Feb;29(1):150881. doi: 10.1016/j.sempedsurg.2020.150881. Epub 2020 Jan 19. Semin Pediatr Surg. 2020. PMID: 32238282 Review.
-
Antwi F, Fazylova N, Garcon MC, Lopez L, Rubiano R, Slyer JT. Antwi F, et al. JBI Libr Syst Rev. 2012;10(42 Suppl):1-14. doi: 10.11124/jbisrir-2012-248. JBI Libr Syst Rev. 2012. PMID: 27820152
-
The Science of Obesity Management: An Endocrine Society Scientific Statement.
Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, Kushner RF, Daniels SR, Wadden TA, Tsai AG, Hu FB, Jakicic JM, Ryan DH, Wolfe BM, Inge TH. Bray GA, et al. Endocr Rev. 2018 Apr 1;39(2):79-132. doi: 10.1210/er.2017-00253. Endocr Rev. 2018. PMID: 29518206 Free PMC article. Review.
-
Jane L, Atkinson G, Jaime V, Hamilton S, Waller G, Harrison S. Jane L, et al. JBI Database System Rev Implement Rep. 2015 Oct;13(10):60-8. doi: 10.11124/jbisrir-2015-2363. JBI Database System Rev Implement Rep. 2015. PMID: 26571283
-
Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, Sosa JA, Sumner AE, Anton B. Golden SH, et al. J Clin Endocrinol Metab. 2012 Sep;97(9):E1579-639. doi: 10.1210/jc.2012-2043. Epub 2012 Jun 22. J Clin Endocrinol Metab. 2012. PMID: 22730516 Free PMC article.
Cited by
-
Systematic preoperative approach for bariatric surgery, perioperative results, and economic impact.
Freire-Moreira I, Sanchez-Conde MP, Sousa GB, Garrido-Gallego MI, Rodríguez-López JM, Juárez-Vela R, Bragado JA, Carretero-Hernández M, Vargas-Chiarella CR, Calderón-Moreno J, Lorenzo-Gómez MF, Vaquero-Roncero LM. Freire-Moreira I, et al. Front Public Health. 2024 Oct 9;12:1439948. doi: 10.3389/fpubh.2024.1439948. eCollection 2024. Front Public Health. 2024. PMID: 39444955 Free PMC article.
-
Retnakaran R, Pu J, Hanley AJ, Connelly PW, Sermer M, Zinman B. Retnakaran R, et al. EClinicalMedicine. 2023 Dec 13;67:102363. doi: 10.1016/j.eclinm.2023.102363. eCollection 2024 Jan. EClinicalMedicine. 2023. PMID: 38314059 Free PMC article.
-
Pharmacotherapy for obesity: moving towards efficacy improvement.
Coutinho W, Halpern B. Coutinho W, et al. Diabetol Metab Syndr. 2024 Jan 3;16(1):6. doi: 10.1186/s13098-023-01233-4. Diabetol Metab Syndr. 2024. PMID: 38172940 Free PMC article.
-
Masoodian SM, Toolabi K, Omidifar A, Zabihi H, Rahimipour A, Shanaki M. Masoodian SM, et al. Rep Biochem Mol Biol. 2020 Apr;9(1):71-81. doi: 10.29252/rbmb.9.1.71. Rep Biochem Mol Biol. 2020. PMID: 32821754 Free PMC article.
-
Chand S, Tripathi AS, Hasan T, Ganesh K, Cordero MAW, Yasir M, Zaki MEA, Tripathi P, Mohapatra L, Maurya RK. Chand S, et al. Nutr Diabetes. 2023 Dec 5;13(1):26. doi: 10.1038/s41387-023-00254-2. Nutr Diabetes. 2023. PMID: 38052812 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Defining adult overweight and obesity. Available at: www.cdc.gov/obesity/adult/defining.html. Accessed 7 June 2017.
-
- Bray G. Battle of the Bulge: A History of Obesity Research. Philadelphia, PA: Dorrance Publishing; 2007.
-
- Cohen PA, Maller G, DeSouza R, Neal-Kababick J. Presence of banned drugs in dietary supplements following FDA recalls. JAMA. 2014;312:1691–1693. - PubMed
-
- Schwartz TB. Henry Harrower and the turbulent beginnings of endocrinology. Ann Intern Med. 1999;131:702–706. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical